1987
TAUNS Laboratories, Inc. was established in Numazu (Shizuoka), to conduct research and development on in vitro diagnostics, research reagents, and various analytical reagents, as well as to develop related systems.
Tokyo office was established and began operation.

1994
A new head office building was constructed in Kozuwa (Numazu, Shizuoka).

2001
A new diagnostic manufacturing plant (Numazu Plant) was constructed in Kozuwa (Numazu, Shizuoka).

2002
The R&D department was spun off to form BL Co., Ltd.

2007
Platinum-gold colloid manufacturing process was patented (Japanese Patent No. 3886000).
A new head office building was constructed in Futaba-cho (Numazu, Shizuoka).

2008
TAUNS took over sales of “Capilia O157,” a diagnostic test kit for E. coli O157 infection, and “Capilia VT,” a diagnostic test kit for enterohemorrhagic E. coli infection, from Nippon Becton Dickinson Company, Ltd.
“ImunoAce Adeno,” a rapid diagnostic test kit for adenovirus infection was launched in Japan. It was the world’s first rapid diagnostic test kit adopting the latest nanotechnology, “platinum-gold colloid.”

“ImunoAce Flu,” a rapid diagnostic test kit for influenza virus infection was launched in Japan.

2010
A research reagent “Line Judge FluA/pdm” was launched in Japan.

2011
“Capilia MAC Ab ELISA,” a diagnostic test kit for MAC pulmonary disease was launched in Japan.
* Sales in Japan have been transferred to Kyokuto Pharmaceutical Industrial Co., Ltd.

2012
Kamishima Plant was newly established in Kamishima (Izunokuni, Shizuoka).

“Capilia TB-Neo,” a diagnostic test kit for tuberculosis was launched in Japan.
* Sales in Japan have been transferred to Kyokuto Pharmaceutical Industrial Co., Ltd.
Head office was relocated to Kamishima (Izunokuni, Shizuoka).
ISO 13485 certification was acquired.
“ImunoAce RSV Neo,” a rapid diagnostic test kit for RS virus infection was launched in Japan.

2013
“ImunoAce Strep A,” a rapid diagnostic test kit for GABHS infection was launched in Japan.

2015
“ImunoAce Mycoplasma,” a rapid diagnostic test kit for mycoplasma infection was launched in Japan.

2016
“ImunoAce hMPV,” a rapid diagnostic test kit for human metapneumovirus infection was launched in Japan.
TAUNS merged with BL Co., Ltd. and integrated its R&D department.

2020
“ImunoAce Flu/RSV,” a rapid diagnostic test kit for influenza virus and/or RS virus infection was launched in Japan.
Shimizu-cho Office/R&D Center was established in Shimizu-cho (Sunto-gun, Shizuoka).

“ImunoAce Strep A Neo,” a rapid diagnostic test kit for GABHS infection was launched in Japan.
“ImunoAce SARS-CoV-2,” a rapid diagnostic test kit for SARS-CoV-2 infection was launched in Japan.

“ImunoAce Noro,” a rapid diagnostic test kit for norovirus infection was launched in Japan.

2021
“ImunoAce SARS-CoV-2 Ⅱ,” a rapid diagnostic test kit for SARS-CoV-2 infection was launched in Japan.